ArticleJournal of translational medicine2008

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.

Felicita Baratelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.